Nuclear Medicine
FLPET (R+D)
Name:
FLPET (R&D)
Active Principle:
3´-DEOXI-3-(18F)-FLUORTHIMIDINE
Therapeutic Action:
It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness of tumors such as Astrocytoma, glioblastoma multiforme, medulloblastoma, oligogastrocytoma, ganglioma, lung cancer, colorectal carcinoma, malignant melanoma, Non-Hodgkin’s lymphoma, breast cancer and pancreatic ductal adenocarcinoma.
Nuclear Medicine
FLPET (R+D)
Name:
FLPET (R&D)
Active Principle:
3´-DEOXI-3-(18F)-FLUORTHIMIDINE
Therapeutic Action:
It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness of tumors such as Astrocytoma, glioblastoma multiforme, medulloblastoma, oligogastrocytoma, ganglioma, lung cancer, colorectal carcinoma, malignant melanoma, Non-Hodgkin’s lymphoma, breast cancer and pancreatic ductal adenocarcinoma.
RELATED PRODUCTS
-
177Lu DOTATATE (I+D)
177Lu DOTATATE (I+D)It is a radiolabeled somatostatin analog indicated for: - The treatment of gastroenteropancreatic tumors positive for the somatostatin receptor. Neuroendocrine tumors (GEP-NETs), including the foregut... -
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test. -
PYROPHOSPHATE
PYROPHOSPHATEIt is indicated for performing bone scintigraphy, detection of cardiac pathologies and "in vivo" and "in vitro" marking of erythrocytes. 1) In vivo, in vitro or in vivo/in vitro marking of red blood cells to... -
PARTITION FLASK
PARTITION FLASKVial containing a mixture of solvents to carry out a chromatographic separation ...

